Trogocytosis of multiple B-cell surface markers by CD22 targeting with epratuzumab.

Abstract:

:Epratuzumab, a humanized anti-CD22 antibody, is currently in clinical trials of B-cell lymphomas and autoimmune diseases, demonstrating therapeutic activity in non-Hodgkin lymphoma (NHL) and systemic lupus erythematosus (SLE). Thus, epratuzumab offers a promising option for CD22-targeted immunotherapy, yet its mechanism of action remains poorly understood. Here we report for the first time that epratuzumab promptly induces a marked decrease of CD22 (>80%), CD19 (>50%), CD21 (>50%), and CD79b (>30%) on the surface of B cells in peripheral blood mononuclear cells (PBMCs) obtained from normal donors or SLE patients, and of NHL cells (Daudi and Raji) spiked into normal PBMCs. Although some Fc-independent loss of CD22 is expected from internalization by epratuzumab, the concurrent and prominent reduction of CD19, CD21, and CD79b is Fc dependent and results from their transfer from epratuzumab-opsonized B cells to FcγR-expressing monocytes, natural killer cells, and granulocytes via trogocytosis. The findings of reduced levels of CD19 are implicative for the efficacy of epratuzumab in autoimmune diseases because elevated CD19 has been correlated with susceptibility to SLE in animal models as well as in patients. This was confirmed herein by the finding that SLE patients receiving epratuzumab immunotherapy had significantly reduced CD19 compared with treatment-naïve patients.

journal_name

Blood

journal_title

Blood

authors

Rossi EA,Goldenberg DM,Michel R,Rossi DL,Wallace DJ,Chang CH

doi

10.1182/blood-2012-12-473744

subject

Has Abstract

pub_date

2013-10-24 00:00:00

pages

3020-9

issue

17

eissn

0006-4971

issn

1528-0020

pii

blood-2012-12-473744

journal_volume

122

pub_type

杂志文章

相关文献

BLOOD文献大全
  • A unique precipitating autoantibody against plasma thromboplastin antecedent associated with multiple apparent plasma clotting factor deficiencies in a patient with systemic lupus erythematosus.

    abstract::A 42-yr-old woman with systemic lupus erythematosus without bleeding diathesis developed a prolonged activated partial thromboplastin time that was not corrected by normal plasma. An inhibitor that acted rapidly and inactivated 0.5 U/ml plasma thromboplastin antecedent (PTA, factor XI) at a 1:200 plasma dilution was d...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Poon MC,Saito H,Koopman WJ

    更新日期:1984-06-01 00:00:00

  • Phosphotyrosine profiling identifies the KG-1 cell line as a model for the study of FGFR1 fusions in acute myeloid leukemia.

    abstract::The 8p11 myeloproliferative syndrome (EMS) is associated with translocations that disrupt the FGFR1 gene. To date, 8 fusion partners of FGFR1 have been identified. However, no primary leukemia cell lines were identified that contain any of these fusions. Here, we screened more than 40 acute myeloid leukemia cell lines...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-06-026666

    authors: Gu TL,Goss VL,Reeves C,Popova L,Nardone J,Macneill J,Walters DK,Wang Y,Rush J,Comb MJ,Druker BJ,Polakiewicz RD

    更新日期:2006-12-15 00:00:00

  • Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience.

    abstract::Although allogeneic hematopoietic stem cell transplantation (HSCT) remains the only curative treatment for patients with Fanconi anemia (FA), published series mostly refer to single-center experience with limited numbers of patients. We analyzed results in 795 patients with FA who underwent first HSCT between May 1972...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2013-01-479733

    authors: Peffault de Latour R,Porcher R,Dalle JH,Aljurf M,Korthof ET,Svahn J,Willemze R,Barrenetxea C,Mialou V,Soulier J,Ayas M,Oneto R,Bacigalupo A,Marsh JC,Peters C,Socie G,Dufour C,FA Committee of the Severe Aplastic Anemia W

    更新日期:2013-12-19 00:00:00

  • Synergistic inhibition of platelet activation by plasmin and prostaglandin I2.

    abstract::Endothelial cell prostacyclin (PGI2) inhibits platelet activation by raising platelet cyclic AMP. Previously, platelet activation was also shown to be blocked by plasmin formed by endothelium-derived tissue plasminogen activator (TPA). We have now studied interactions between PGI2 and plasmin in the control of platele...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Schafer AI,Zavoico GB,Loscalzo J,Maas AK

    更新日期:1987-05-01 00:00:00

  • A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gammaglobulin.

    abstract::A decrease in inhibitor titer has been reported in some patients with acquired factor VIII inhibitors treated with intravenous gammaglobulin (IGIV). We have conducted a prospective, multicenter study of high-dose IGIV in treatment of this disorder to determine efficacy. Nineteen patients received induction therapy wit...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Schwartz RS,Gabriel DA,Aledort LM,Green D,Kessler CM

    更新日期:1995-07-15 00:00:00

  • Expression of cytokine receptors on follicular dendritic cells.

    abstract::Follicular dendritic cells (FDCs) in the lymphoid follicle (LF) are essential to the sequential processes of B-cell proliferation, selection, and differentiation. Although the importance of some cytokines in these processes has been pointed out, there is little information about the follicular localization of their re...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Yamada K,Yamakawa M,Imai Y,Tsukamoto M

    更新日期:1997-12-15 00:00:00

  • Bif-1 haploinsufficiency promotes chromosomal instability and accelerates Myc-driven lymphomagenesis via suppression of mitophagy.

    abstract::Malignant transformation by oncogenes requires additional genetic/epigenetic changes to overcome enhanced susceptibility to apoptosis. In the present study, we report that Bif-1 (Sh3glb1), a gene encoding a membrane curvature–driving endophilin protein, is a haploinsufficient tumor suppressor that plays a key role in ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-10-459826

    authors: Takahashi Y,Hori T,Cooper TK,Liao J,Desai N,Serfass JM,Young MM,Park S,Izu Y,Wang HG

    更新日期:2013-02-28 00:00:00

  • Correlation of minor histocompatibility antigen-specific cytotoxic T lymphocytes with graft-versus-host disease status and analyses of tissue distribution of their target antigens.

    abstract::Peripheral blood mononuclear cells (PBMC) from 17 patients receiving HLA-identical sibling bone marrow grafts were stimulated with host pretransplant PBMC. Cytotoxic T-cell lines (TCL) with specificity for host pretransplant PBMC were obtained from 9 of these patients, all presenting with severe graft-versus-host dise...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Niederwieser D,Grassegger A,Auböck J,Herold M,Nachbaur D,Rosenmayr A,Gächter A,Nussbaumer W,Gaggl S,Ritter M

    更新日期:1993-04-15 00:00:00

  • Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia.

    abstract::The primary objective was to describe the prevalence and characteristics of microbiologically defined infections and infection-related mortality (IRM) in 492 children with acute myeloid leukemia enrolled on CCG 2961. Secondary objectives were to determine the relationship between demographic, disease-related, and ther...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2007-05-091942

    authors: Sung L,Lange BJ,Gerbing RB,Alonzo TA,Feusner J

    更新日期:2007-11-15 00:00:00

  • Superior effects of high-dose enzyme replacement therapy in type 1 Gaucher disease on bone marrow involvement and chitotriosidase levels: a 2-center retrospective analysis.

    abstract::Dosing of enzyme replacement therapy (ERT) for Gaucher disease type 1 is still a subject of debate and varies from 15 to 130 U/kg/mo, making a huge economic difference of 70,000 US dollars to 380,000 US dollars(euro55,000-300,000) per patient per year. To investigate whether this difference in dosing ultimately transl...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2005-12-5072

    authors: de Fost M,Hollak CE,Groener JE,Aerts JM,Maas M,Poll LW,Wiersma MG,Häussinger D,Brett S,Brill N,vom Dahl S

    更新日期:2006-08-01 00:00:00

  • Chlorambucil therapy in hairy cell leukemia: effects on lipid composition and lymphocyte subpopulations.

    abstract::Two patients with progressive hairy cell leukemia following splenectomy were treated with low-dose daily chlorambucil. Both had an objective hematologic response as determined by a return to normal hematocrit and platelet count. This was also reflected in the mononuclear cell fraction by the normalization of cholester...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Krigel R,Liebes LF,Pelle E,Silber R

    更新日期:1982-07-01 00:00:00

  • Preferential nuclear accumulation of JAK2V617F in CD34+ but not in granulocytic, megakaryocytic, or erythroid cells of patients with Philadelphia-negative myeloproliferative neoplasia.

    abstract::Recently, Dawson et al identified a previously unrecognized nuclear role of JAK2 in the phosphorylation of histone H3 in hematopoietic cell lines. We searched nuclear JAK2 in total bone marrow (BM) cells and in 4 sorted BM cell populations (CD34(+), CD15(+), CD41(+), and CD71(+)) of 10 myeloproliferative neoplasia (MP...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-08-302265

    authors: Rinaldi CR,Rinaldi P,Alagia A,Gemei M,Esposito N,Formiggini F,Martinelli V,Senyuk V,Nucifora G,Pane F

    更新日期:2010-12-23 00:00:00

  • Blastic transformation of essential thrombocythemia: dual expression of myelomonoblastic/megakaryoblastic phenotypes.

    abstract::Three patients developed blastic transformation of essential thrombocythemia (tET). Morphological studies in all patients showed that the majority of blasts had either myeloblastic or myelomonoblastic differentiation. Immunologic assays of hematopoietic cells were performed in two patients. In patient 1, 86% of periph...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Frei-Lahr D,Barton JC,Hoffman R,Burkett LL,Prchal JT

    更新日期:1984-04-01 00:00:00

  • Treatment of baboon with vinblastine: insights into the mechanisms of pharmacologic stimulation of Hb F in the adult.

    abstract::Vinblastine was administered to anemic baboons to test whether stimulation of Hb F takes place following distortion of erythropoiesis by an M-stage-specific compound. The treatments elicited erythroid cell cytoreduction followed by regeneration. During the phase of reticulocyte reduction, gamma/gamma + beta biosynthet...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Veith R,Papayannopoulou T,Kurachi S,Stamatoyannopoulos G

    更新日期:1985-08-01 00:00:00

  • Host natural killer T cells induce an interleukin-4-dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host disease.

    abstract::Although CD4(+)CD25(+) T cells (T regulatory cells [Tregs]) and natural killer T cells (NKT cells) each protect against graft-versus-host disease (GVHD), interactions between these 2 regulatory cell populations after allogeneic bone marrow transplantation (BMT) have not been studied. We show that host NKT cells can in...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-06-165506

    authors: Pillai AB,George TI,Dutt S,Strober S

    更新日期:2009-04-30 00:00:00

  • Molecular basis for type 1 antithrombin deficiency: identification of two novel point mutations and evidence for a de novo splice site mutation.

    abstract::Inherited type 1 antithrombin (AT) deficiency is characterized by a reduction in both immunologically and functionally detectable protein. The disorder is associated with a high risk of thromboembolic disease. We have investigated the molecular basis of type 1 AT deficiency in three unrelated families. We have used th...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Jochmans K,Lissens W,Yin T,Michiels JJ,van der Luit L,Peerlinck K,De Waele M,Liebaers I

    更新日期:1994-12-01 00:00:00

  • Downregulation of the anti-HLA alloimmune response by variable region-reactive (anti-idiotypic) antibodies in leukemic patients transfused with platelet concentrates.

    abstract::Approximately 30% to 40% of patients with acute leukemia receiving repeated pooled random-donor platelet transfusions develop anti-HLA alloantibodies. Over time, however, serum anti-HLA concentrations decrease in approximately 50% of these patients, despite continued exposure to platelet and/or red blood cell transfus...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Atlas E,Freedman J,Blanchette V,Kazatchkine MD,Semple JW

    更新日期:1993-01-15 00:00:00

  • Retention of B-cell-specific monoclonal antibodies by human lymphoma cells.

    abstract::The rates of endocytosis, intracellular degradation, and cell-surface shedding of 125I-labeled monoclonal antibodies (MoAbs) HD-37 (anti-CD19), B1 (anti-CD20), MB-1 (anti-CD37), BC8 (anti-CD45), and DA4-4 (anti-mu) by B-lymphoma cells were compared by cellular radioimmunoassay, ultrastructural autoradiography, sodium ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Press OW,Howell-Clark J,Anderson S,Bernstein I

    更新日期:1994-03-01 00:00:00

  • Effect of transforming growth factor-beta 1 on proliferation and induction of hemoglobin accumulation in K-562 cells.

    abstract::The effects of transforming growth factor-beta 1 (TGF-beta 1) on proliferation and hemoglobinization in K-562 cells, a human multipotential hematopoietic cell line, were studied. We found that TGF-beta 1 could induce hemoglobin accumulation in K-562 cells. Various clones were selected on the basis of the inducibility ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Chen LL,Dean A,Jenkinson T,Mendelsohn J

    更新日期:1989-11-15 00:00:00

  • Correction of hypercoagulability and amelioration of pulmonary arterial hypertension by chronic blood transfusion in an asplenic hemoglobin E/beta-thalassemia patient.

    abstract::Chronic transfusion of packed red blood cells, in addition to other ongoing treatment with warfarin, acetyl salicylic acid, desferrioxamine, and other supportive measures, was given to a splenectomized hemoglobin E/beta-thalassemia woman with pulmonary arterial hypertension (PHT). Serial measurements of plasma thrombi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-09-3094

    authors: Atichartakarn V,Chuncharunee S,Chandanamattha P,Likittanasombat K,Aryurachai K

    更新日期:2004-04-01 00:00:00

  • Comparative analysis of predicted HLA binding of immunoglobulin idiotype sequences indicates T cell-mediated immunosurveillance in follicular lymphoma.

    abstract::Active immunization with the idiotype of follicular lymphoma induces tumor-specific immunity. T cells induced in vivo by idiotype vaccination recognize human leukocyte antigen (HLA)--restricted hypervariable but not conserved idiotype peptides. We hypothesized that idiotype-directed T-cell immunity occurs naturally an...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-02-270199

    authors: Strothmeyer AM,Papaioannou D,Dühren-von Minden M,Navarrete M,Zirlik K,Heining-Mikesch K,Veelken H

    更新日期:2010-09-09 00:00:00

  • The tumor marker Fascin is strongly induced by the Tax oncoprotein of HTLV-1 through NF-kappaB signals.

    abstract::Oncogenic transformation of CD4(+) T cells by human T-cell lymphotropic virus type 1 (HTLV-1) is understood as the initial step to adult T-cell leukemia/lymphoma, a process that is mainly initiated by perturbation of cellular signaling by the viral Tax oncoprotein, a potent transcriptional regulator. In search of nove...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-09-305805

    authors: Kress AK,Kalmer M,Rowan AG,Grassmann R,Fleckenstein B

    更新日期:2011-03-31 00:00:00

  • Ikaros limits basophil development by suppressing C/EBP-α expression.

    abstract::The Ikaros gene (Ikzf1) encodes a family of zinc-finger transcription factors implicated in hematopoietic cell differentiation. Here we show that Ikaros suppresses the development of basophils, which are proinflammatory cells of the myeloid lineage. In the absence of extrinsic basophil-inducing signals, Ikaros(-/-) (I...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-04-494625

    authors: Rao KN,Smuda C,Gregory GD,Min B,Brown MA

    更新日期:2013-10-10 00:00:00

  • Genistein reduces tumor necrosis factor alpha-induced plasminogen activator inhibitor-1 transcription but not urokinase expression in human endothelial cells.

    abstract::The plasminogen activator inhibitor PAI-1 is markedly elevated in vivo and in vitro upon exposure to the inflammatory mediators tumor necrosis factor alpha (TNF alpha), interleukin-1 (IL-1), and bacterial lipopolysaccharide. Here we report that the isoflavone compound genistein prevents the increase in synthesis of PA...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: van Hinsbergh VW,Vermeer M,Koolwijk P,Grimbergen J,Kooistra T

    更新日期:1994-11-01 00:00:00

  • Nbeal2 interacts with Dock7, Sec16a, and Vac14.

    abstract::Mutations in NBEAL2, the gene encoding the scaffolding protein Nbeal2, are causal of gray platelet syndrome (GPS), a rare recessive bleeding disorder characterized by platelets lacking α-granules and progressive marrow fibrosis. We present here the interactome of Nbeal2 with additional validation by reverse immunoprec...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2017-08-800359

    authors: Mayer L,Jasztal M,Pardo M,Aguera de Haro S,Collins J,Bariana TK,Smethurst PA,Grassi L,Petersen R,Nurden P,Favier R,Yu L,Meacham S,Astle WJ,Choudhary J,Yue WW,Ouwehand WH,Guerrero JA

    更新日期:2018-03-01 00:00:00

  • Tuning the volume of the immune response: strength and persistence of stimulation determine migration and cytokine secretion of dendritic cells.

    abstract::Migration to lymph nodes and secretion of cytokines are critical functions of mature dendritic cells (DCs); however, these 2 functions are not necessarily linked. This is the first report showing that quantitative differences in identical signaling pathways determine DC migration and cytokine secretion. Using differen...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-12-4146

    authors: Luft T,Maraskovsky E,Schnurr M,Knebel K,Kirsch M,Görner M,Skoda R,Ho AD,Nawroth P,Bierhaus A

    更新日期:2004-08-15 00:00:00

  • POEMS syndrome: definitions and long-term outcome.

    abstract::The POEMS syndrome (coined to refer to polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes) remains poorly understood. Ambiguity exists over the features necessary to establish the diagnosis, treatment efficacy, and prognosis. We identified 99 patients with POEMS syndrome. Minimal criteria were a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-07-2299

    authors: Dispenzieri A,Kyle RA,Lacy MQ,Rajkumar SV,Therneau TM,Larson DR,Greipp PR,Witzig TE,Basu R,Suarez GA,Fonseca R,Lust JA,Gertz MA

    更新日期:2003-04-01 00:00:00

  • Somatic mosaicism for oncogenic NRAS mutations in juvenile myelomonocytic leukemia.

    abstract::Juvenile myelomonocytic leukemia (JMML) is a rare pediatric myeloid neoplasm characterized by excessive proliferation of myelomonocytic cells. Somatic mutations in genes involved in GM-CSF signal transduction, such as NRAS, KRAS, PTPN11, NF1, and CBL, have been identified in more than 70% of children with JMML. In the...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-02-406090

    authors: Doisaki S,Muramatsu H,Shimada A,Takahashi Y,Mori-Ezaki M,Sato M,Kawaguchi H,Kinoshita A,Sotomatsu M,Hayashi Y,Furukawa-Hibi Y,Yamada K,Hoshino H,Kiyoi H,Yoshida N,Sakaguchi H,Narita A,Wang X,Ismael O,Xu Y,Nishio N

    更新日期:2012-08-16 00:00:00

  • Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders.

    abstract::An acquired gain-of-function mutation in the Janus kinase 2 (JAK2-V617F) is frequently found in patients with myeloproliferative disorders (MPDs). To test the hypothesis that JAK2-V617F is the disease-initiating mutation, we examined whether all cells of clonal origin carry the JAK2-V617F mutation. Using allele-specif...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2005-11-009605

    authors: Kralovics R,Teo SS,Li S,Theocharides A,Buser AS,Tichelli A,Skoda RC

    更新日期:2006-08-15 00:00:00

  • Up-regulation of vascular endothelial growth factor receptor Flt-1 after endothelial denudation: role of transcription factor Egr-1.

    abstract::Vascular endothelial growth factor (VEGF) is highly expressed in vascular remodeling processes and accelerates reendothelialization after mechanical denudation. Two VEGF tyrosine kinase receptors have been reported-fms-like-tyrosine kinase-1 (Flt-1) and kinase domain region (KDR). Little is known about the regulation ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Vidal F,Aragonés J,Alfranca A,de Landázuri MO

    更新日期:2000-06-01 00:00:00